$2.54 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 106 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 44.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | HORIZON PHARMA PLC | $226,302,000 | -0.6% | 13,740,261 | 0.0% | 8.89% | -8.3% | |
| NXTM | Sell | NXSTAGE MEDICAL INC | $97,679,000 | +18.3% | 4,505,468 | -18.2% | 3.84% | +9.2% |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $90,819,000 | +86.7% | 991,800 | +47.1% | 3.57% | +72.2% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $86,700,000 | +37.5% | 3,673,727 | +18.9% | 3.41% | +26.9% |
| AVXS | AVEXIS INC | $85,039,000 | +39.6% | 2,236,701 | 0.0% | 3.34% | +28.8% | |
| ADPTQ | Buy | ADEPTUS HEALTH INCcl a | $82,700,000 | +55.7% | 1,600,861 | +67.4% | 3.25% | +43.7% |
| XNPT | XENOPORT INC | $81,468,000 | +56.1% | 11,572,125 | 0.0% | 3.20% | +44.1% | |
| HORIZON PHARMA INVT LTDnote 2.500% 3/1 | $75,166,000 | +6.7% | 82,600,000 | 0.0% | 2.95% | -1.6% | ||
| HEALTHWAYS INCnote 1.500% 7/0 | $72,000,000 | +2.0% | 76,925,000 | 0.0% | 2.83% | -5.9% | ||
| VNDA | VANDA PHARMACEUTICALS INC | $67,103,000 | +33.9% | 5,996,691 | 0.0% | 2.64% | +23.6% | |
| MYL | Sell | MYLAN N V | $57,913,000 | -31.8% | 1,339,334 | -26.9% | 2.28% | -37.1% |
| DBVT | Buy | DBV TECHNOLOGIES S Asponsored adr | $56,864,000 | +113.6% | 1,743,229 | +113.2% | 2.24% | +97.3% |
| XNCR | Sell | XENCOR INC | $55,650,000 | +19.6% | 2,930,486 | -15.5% | 2.19% | +10.4% |
| WBA | Buy | WALGREENS BOOTS ALLIANCE INC | $50,916,000 | +18.2% | 611,457 | +19.6% | 2.00% | +9.1% |
| AACH | Sell | AAC HLDGS INC | $49,056,000 | +8.0% | 2,149,702 | -6.3% | 1.93% | -0.3% |
| AET | Sell | AETNA INC NEW | $44,700,000 | -32.7% | 366,000 | -38.1% | 1.76% | -37.9% |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $44,362,000 | +38.6% | 2,520,585 | -4.3% | 1.74% | +27.9% |
| New | TRINITY BIOTECH INVT LTDnote 4.000% 4/0 | $43,935,000 | – | 48,000,000 | +100.0% | 1.73% | – | |
| FLML | FLAMEL TECHNOLOGIES SAsponsored adr | $43,742,000 | -2.7% | 4,072,809 | 0.0% | 1.72% | -10.2% | |
| EDIT | EDITAS MEDICINE INC | $41,709,000 | -29.4% | 1,709,400 | 0.0% | 1.64% | -34.8% | |
| DVA | Sell | DAVITA HEALTHCARE PARTNERS I | $40,593,000 | -32.7% | 525,000 | -36.1% | 1.60% | -37.9% |
| Buy | HEARTWARE INTL INCnote 3.500%12/1 | $39,689,000 | +8.7% | 40,226,000 | +2.5% | 1.56% | +0.4% | |
| SYRS | New | SYROS PHARMACEUTICALS INC | $38,028,000 | – | 2,095,220 | +100.0% | 1.50% | – |
| ARRAY BIOPHARMA INCnote 3.000% 6/0 | $37,815,000 | +5.4% | 45,000,000 | 0.0% | 1.49% | -2.7% | ||
| ENDOLOGIX INCnote 2.250%12/1 | $37,787,000 | +26.5% | 40,941,000 | 0.0% | 1.48% | +16.7% | ||
| EHTH | Sell | EHEALTH INC | $37,021,000 | +20.8% | 2,640,609 | -19.1% | 1.46% | +11.5% |
| WRIGHT MED GROUP INCnote 2.000% 2/1 | $36,749,000 | +2.2% | 40,050,000 | 0.0% | 1.44% | -5.7% | ||
| ZLTQ | Buy | ZELTIQ AESTHETICS INC | $35,447,000 | +18.2% | 1,297,000 | +17.4% | 1.39% | +9.1% |
| UAM | Sell | UNIVERSAL AMERN CORP NEW | $32,768,000 | -13.2% | 4,323,000 | -18.2% | 1.29% | -19.9% |
| RLYP | Sell | RELYPSA INC | $30,902,000 | +21.7% | 1,670,383 | -10.8% | 1.21% | +12.3% |
| New | HEARTWARE INTL INCnote 1.750%12/1 | $29,939,000 | – | 30,271,000 | +100.0% | 1.18% | – | |
| ARRY | Sell | ARRAY BIOPHARMA INC | $29,765,000 | +5.9% | 8,361,069 | -12.3% | 1.17% | -2.3% |
| HWAY | Buy | HEALTHWAYS INC | $29,356,000 | +17.5% | 2,541,686 | +2.7% | 1.15% | +8.6% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $28,764,000 | +51.9% | 1,733,828 | +45.2% | 1.13% | +40.2% |
| GKOS | New | GLAUKOS CORP | $28,697,000 | – | 984,112 | +100.0% | 1.13% | – |
| HUM | New | HUMANA INC | $28,691,000 | – | 159,500 | +100.0% | 1.13% | – |
| ACOR | ACORDA THERAPEUTICS INC | $26,255,000 | -3.6% | 1,029,410 | 0.0% | 1.03% | -11.0% | |
| GLPG | Buy | GALAPAGOS NVspon adr | $25,411,000 | +85.5% | 458,112 | +39.8% | 1.00% | +71.4% |
| AXGN | AXOGEN INC | $23,264,000 | +28.4% | 3,381,439 | 0.0% | 0.91% | +18.4% | |
| CI | New | CIGNA CORPORATION | $21,886,000 | – | 171,000 | +100.0% | 0.86% | – |
| MOH | New | MOLINA HEALTHCARE INC | $21,756,000 | – | 436,000 | +100.0% | 0.86% | – |
| LCI | New | LANNET INC | $21,306,000 | – | 895,591 | +100.0% | 0.84% | – |
| RAD | Buy | RITE AID CORP | $19,561,000 | +0.3% | 2,611,580 | +9.1% | 0.77% | -7.3% |
| COTV | New | COTIVITI HLDGS INC | $19,019,000 | – | 900,079 | +100.0% | 0.75% | – |
| ONCE | New | SPARK THERAPEUTICS INC | $18,816,000 | – | 368,000 | +100.0% | 0.74% | – |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $18,645,000 | – | 336,000 | +100.0% | 0.73% | – |
| FPRX | Sell | FIVE PRIME THERAPEUTICS INC | $18,525,000 | -32.9% | 448,000 | -34.1% | 0.73% | -38.1% |
| ZFGN | ZAFGEN INC | $18,303,000 | -10.3% | 3,055,603 | 0.0% | 0.72% | -17.3% | |
| NVLS | NIVALIS THERAPEUTICS INC | $17,169,000 | +10.3% | 3,732,412 | 0.0% | 0.68% | +1.8% | |
| FLUIDIGM CORP DELnote 2.750% 2/0 | $16,658,000 | +8.5% | 27,715,000 | 0.0% | 0.66% | +0.2% | ||
| AKTX | AKARI THERAPEUTICS PLCsponsored adr | $15,523,000 | -3.6% | 1,150,700 | 0.0% | 0.61% | -11.1% | |
| BLUE | New | BLUEBIRD BIO INC | $14,636,000 | – | 338,085 | +100.0% | 0.58% | – |
| SEM | Buy | SELECT MED HLDGS CORP | $14,315,000 | +116.8% | 1,316,944 | +135.5% | 0.56% | +100.4% |
| IVTY | INVUITY INC | $12,646,000 | +32.0% | 1,327,009 | 0.0% | 0.50% | +21.8% | |
| PRTO | Buy | PROTEON THERAPEUTICS INC | $12,463,000 | +27.3% | 1,552,031 | +22.7% | 0.49% | +17.5% |
| Sell | SPECTRANETICS CORPmtnf 2.625% 6/0 | $11,232,000 | -52.5% | 12,731,000 | -57.3% | 0.44% | -56.2% | |
| CTMX | CYTOMX THERAPEUTICS INC | $9,637,000 | -20.8% | 943,433 | 0.0% | 0.38% | -26.8% | |
| RGNX | REGENXBIO INC | $9,352,000 | -25.9% | 1,169,042 | 0.0% | 0.37% | -31.6% | |
| NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $8,500,000 | -7.9% | 674,622 | +11.3% | 0.33% | -15.0% |
| FOMX | Buy | FOAMIX PHARMACEUTICALS LTD | $8,141,000 | +31.6% | 1,282,058 | +35.1% | 0.32% | +21.7% |
| BIOS | New | BIOSCRIP INC | $7,616,000 | – | 2,986,800 | +100.0% | 0.30% | – |
| INCY | New | INCYTE CORP | $7,278,000 | – | 91,000 | +100.0% | 0.29% | – |
| ALIM | ALIMERA SCIENCES INC | $7,230,000 | -29.7% | 5,878,015 | 0.0% | 0.28% | -35.2% | |
| New | AMAG PHARMACEUTICALS INCnote 2.500% 2/1 | $7,161,000 | – | 6,500,000 | +100.0% | 0.28% | – | |
| EPZM | New | EPIZYME INC | $6,372,000 | – | 622,299 | +100.0% | 0.25% | – |
| Sell | ESSA PHARMA INC | $6,364,000 | -24.3% | 2,157,151 | -16.6% | 0.25% | -30.2% | |
| GI | Sell | ENDOCHOICE HLDGS INC | $5,875,000 | -38.2% | 1,198,950 | -34.2% | 0.23% | -42.8% |
| CASM | CAS MED SYS INC | $5,888,000 | +29.6% | 3,200,000 | 0.0% | 0.23% | +19.7% | |
| LOXO | LOXO ONCOLOGY INC | $5,818,000 | -15.2% | 251,000 | 0.0% | 0.23% | -21.6% | |
| KMPH | KEMPHARM INC | $5,654,000 | -72.5% | 1,420,497 | 0.0% | 0.22% | -74.7% | |
| ARLZ | ARALEZ PHARMACEUTICALS INC | $5,427,000 | -7.0% | 1,644,583 | 0.0% | 0.21% | -14.5% | |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $5,199,000 | +4.2% | 2,331,366 | -2.8% | 0.20% | -3.8% |
| ADHD | ALCOBRA LTD | $4,804,000 | +18.5% | 1,069,914 | 0.0% | 0.19% | +9.2% | |
| MYOK | MYOKARDIA INC | $4,648,000 | +15.8% | 374,800 | 0.0% | 0.18% | +7.0% | |
| STDY | STEADYMED LTD | $4,404,000 | +32.9% | 1,346,744 | 0.0% | 0.17% | +22.7% | |
| NEOS | NEOS THERAPEUTICS INC | $4,253,000 | -14.0% | 458,332 | 0.0% | 0.17% | -20.9% | |
| PSDV | PSIVIDA CORP | $4,225,000 | +5.6% | 1,492,824 | 0.0% | 0.17% | -2.4% | |
| OXFD | OXFORD IMMUNOTEC GLOBAL PLC | $4,181,000 | -9.2% | 464,541 | 0.0% | 0.16% | -16.3% | |
| SCYX | Buy | SCYNEXIS INC | $3,848,000 | +12.6% | 1,773,177 | +109.1% | 0.15% | +4.1% |
| DNAI | Sell | PRONAI THERAPEUTICS INC | $3,201,000 | -84.2% | 1,608,702 | -46.4% | 0.13% | -85.4% |
| GNCA | Sell | GENOCEA BIOSCIENCES INC | $2,818,000 | -53.8% | 687,257 | -12.7% | 0.11% | -57.1% |
| VYGR | VOYAGER THERAPEUTICS INC | $2,586,000 | +25.9% | 235,294 | 0.0% | 0.10% | +17.2% | |
| INFI | Sell | INFINITY PHARMACEUTICALS INC | $2,575,000 | -88.9% | 1,935,942 | -56.0% | 0.10% | -89.8% |
| CATB | CATABASIS PHARMACEUTICALS IN | $2,381,000 | -26.6% | 643,580 | 0.0% | 0.09% | -31.9% | |
| ARDX | ARDELYX INC | $2,401,000 | +12.4% | 275,000 | 0.0% | 0.09% | +3.3% | |
| CLVS | New | CLOVIS ONCOLOGY INC | $2,326,000 | – | 169,506 | +100.0% | 0.09% | – |
| ACUR | ACURA PHARMACEUTICALS INC | $1,897,000 | -34.7% | 1,025,641 | 0.0% | 0.08% | -39.5% | |
| AGRX | AGILE THERAPEUTICS INC | $1,903,000 | +22.5% | 250,000 | 0.0% | 0.08% | +13.6% | |
| ATEC | ALPHATEC HOLDINGS INC | $1,745,000 | +45.9% | 4,982,738 | 0.0% | 0.07% | +35.3% | |
| PCRX | New | PACIRA PHARMACEUTICALS INC | $1,687,000 | – | 50,000 | +100.0% | 0.07% | – |
| INNL | New | INNOCOLL HLDGS PLC | $1,669,000 | – | 302,923 | +100.0% | 0.07% | – |
| THLD | New | THRESHOLD PHARMACEUTICAL INC | $1,641,000 | – | 2,583,160 | +100.0% | 0.06% | – |
| TRILLIUM THERAPEUTICS INC | $1,547,000 | -2.9% | 172,307 | 0.0% | 0.06% | -10.3% | ||
| ALDX | Sell | ALDEYRA THERAPEUTICS INC | $1,524,000 | -22.8% | 267,764 | -43.2% | 0.06% | -28.6% |
| PRTK | New | PARATEK PHARMACEUTICALS INC | $1,391,000 | – | 100,000 | +100.0% | 0.06% | – |
| OCRX | Buy | OCERA THERAPEUTICS INC | $1,088,000 | +392.3% | 572,893 | +660.9% | 0.04% | +377.8% |
| CORSICANTO LTDnote 3.500% 1/1 | $1,021,000 | +24.4% | 1,000,000 | 0.0% | 0.04% | +14.3% | ||
| CYNA | New | CYNAPSUS THERAPEUTICS INC | $818,000 | – | 48,840 | +100.0% | 0.03% | – |
| EGLTQ | Sell | EGALET CORP | $805,000 | -80.3% | 162,288 | -72.8% | 0.03% | -81.6% |
| STRM | STREAMLINE HEALTH SOLUTIONS | $796,000 | -14.9% | 662,971 | 0.0% | 0.03% | -22.5% | |
| ENDP | New | ENDO INTL PLC | $468,000 | – | 30,000 | +100.0% | 0.02% | – |
| PACB | New | PACIFIC BIOSCIENCES CALIF IN | $444,000 | – | 63,072 | +100.0% | 0.02% | – |
| TCON | Sell | TRACON PHARMACEUTICALS INC | $296,000 | -89.3% | 67,567 | -83.0% | 0.01% | -89.8% |
| CDNA | Sell | CAREDX INC | $221,000 | -80.5% | 51,204 | -77.6% | 0.01% | -81.2% |
| RNVA | Sell | RENNOVA HEALTH INC | $111,000 | -58.1% | 176,425 | -50.2% | 0.00% | -63.6% |
| RENNOVA HEALTH INC*w exp 12/30/202 | $27,000 | -47.1% | 645,161 | 0.0% | 0.00% | -50.0% | ||
| WMGI | Exit | WRIGHT MED GROUP N V | $0 | – | -30,000 | -100.0% | -0.02% | – |
| ALQA | Exit | ALLIQUA BIOMEDICAL INC | $0 | – | -667,246 | -100.0% | -0.02% | – |
| PTN | Exit | PALATIN TECHNOLOGIES INC | $0 | – | -985,693 | -100.0% | -0.02% | – |
| PFE | Exit | PFIZER INC | $0 | – | -25,000 | -100.0% | -0.03% | – |
| CDTX | Exit | CIDARA THERAPEUTICS INC | $0 | – | -68,779 | -100.0% | -0.04% | – |
| VCYT | Exit | VERACYTE INC | $0 | – | -165,097 | -100.0% | -0.04% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -3,500 | -100.0% | -0.04% | – |
| TRUP | Exit | TRUPANION INC | $0 | – | -155,236 | -100.0% | -0.06% | – |
| TNXP | Exit | TONIX PHARMACEUTICALS HLDG C | $0 | – | -1,315,551 | -100.0% | -0.14% | – |
| ABMD | Exit | ABIOMED INC | $0 | – | -49,797 | -100.0% | -0.20% | – |
| ELGX | Exit | ENDOLOGIX INC | $0 | – | -569,895 | -100.0% | -0.20% | – |
| Exit | JAZZ INVESTMENTS I LTDnote 1.875% 8/1 | $0 | – | -5,000,000 | -100.0% | -0.22% | – | |
| Exit | CEPHEIDdbcv 1.250% 2/0 | $0 | – | -7,750,000 | -100.0% | -0.30% | – | |
| XLRN | Exit | ACCELERON PHARMA INC | $0 | – | -353,491 | -100.0% | -0.40% | – |
| MGNX | Exit | MACROGENICS INC | $0 | – | -517,920 | -100.0% | -0.41% | – |
| IMPR | Exit | IMPRIVATA INC | $0 | – | -983,366 | -100.0% | -0.53% | – |
| NVAX | Exit | NOVAVAX INC | $0 | – | -2,456,261 | -100.0% | -0.54% | – |
| ANTM | Exit | ANTHEM INC | $0 | – | -102,000 | -100.0% | -0.60% | – |
| HTWR | Exit | HEARTWARE INTL INC | $0 | – | -870,634 | -100.0% | -1.16% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -175,000 | -100.0% | -1.17% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -1,113,654 | -100.0% | -1.52% | – |
| Exit | ENDOLOGIX INCnote 3.250%11/0 | $0 | – | -40,000,000 | -100.0% | -1.64% | – | |
| GSK | Exit | GLAXOSMITHKLINE PLCsponsored adr | $0 | – | -1,675,385 | -100.0% | -2.89% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.